[Gastric cancer].
Radiochemotherapy Gatrointestinal intergroup study have demonstrated a convincing local control and overall survival benefit. Oncologists and GI workshops have in the present not had a major interest in the radiotherapy treatment of gastric cancer due to a number of factors. Primary because toxicities may be severe, second physicians may have low experience in definition of clinical target volume and in third perioperative chemotherapy is widely used in this indication. In Summary this issue should be used as guides for defining appropriate radiation planning treatment for the adjuvant postoperative therapy of gastric cancer.
Unité de cancérologie digestive, Institut Sainte Catherine, Chemin du Lavarin, 84000 Avignon cedex, France. mineur@isc84.org
L
L
Mineur
E
E
Jaegle
Y
Y
Pointreau
F
F
Denis
D003131:Combined Modality Therapy / Q000379:methods; D005770:Gastrointestinal Neoplasms / Q000532:radiotherapy; D006801:Humans; D011878:Radiotherapy / Q000009:adverse effects*; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods; D018714:Radiotherapy, Adjuvant / Q000379:methods*; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery; D015996:Survival Rate